Trial Profile
Angiographic outcomes of everolimus eluting stent (PtCr-EES) compared to zotarolimus-eluting stent (Resolute) implantation for stent restenosis lesions in patients with coronary artery disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 24 Nov 2016 New trial record